5272 related articles for article (PubMed ID: 19798065)
21. High-fat diet followed by fasting disrupts circadian expression of adiponectin signaling pathway in muscle and adipose tissue.
Barnea M; Madar Z; Froy O
Obesity (Silver Spring); 2010 Feb; 18(2):230-8. PubMed ID: 19713948
[TBL] [Abstract][Full Text] [Related]
22. Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high-fat diet.
Zhang W; Liu CQ; Wang PW; Sun SY; Su WJ; Zhang HJ; Li XJ; Yang SY
Eur J Pharmacol; 2010 Dec; 649(1-3):398-402. PubMed ID: 20869961
[TBL] [Abstract][Full Text] [Related]
23. Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.
Wiedemann MS; Wueest S; Item F; Schoenle EJ; Konrad D
Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E388-95. PubMed ID: 23736545
[TBL] [Abstract][Full Text] [Related]
24. Antiobesity effects of yerba maté extract (Ilex paraguariensis) in high-fat diet-induced obese mice.
Arçari DP; Bartchewsky W; dos Santos TW; Oliveira KA; Funck A; Pedrazzoli J; de Souza MF; Saad MJ; Bastos DH; Gambero A; Carvalho Pde O; Ribeiro ML
Obesity (Silver Spring); 2009 Dec; 17(12):2127-33. PubMed ID: 19444227
[TBL] [Abstract][Full Text] [Related]
25. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice.
Karagiannides I; Abdou R; Tzortzopoulou A; Voshol PJ; Kypreos KE
FEBS J; 2008 Oct; 275(19):4796-809. PubMed ID: 18754772
[TBL] [Abstract][Full Text] [Related]
27. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC
Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274
[TBL] [Abstract][Full Text] [Related]
28. Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program.
Andersson U; Henriksson E; Ström K; Alenfall J; Göransson O; Holm C
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E111-21. PubMed ID: 20959531
[TBL] [Abstract][Full Text] [Related]
29. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice.
Poggi M; Engel D; Christ A; Beckers L; Wijnands E; Boon L; Driessen A; Cleutjens J; Weber C; Gerdes N; Lutgens E
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2251-60. PubMed ID: 21817098
[TBL] [Abstract][Full Text] [Related]
30. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.
Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M
Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970
[TBL] [Abstract][Full Text] [Related]
31. Bixin activates PPARα and improves obesity-induced abnormalities of carbohydrate and lipid metabolism in mice.
Goto T; Takahashi N; Kato S; Kim YI; Kusudo T; Taimatsu A; Egawa K; Kang MS; Hiramatsu T; Sakamoto T; Uemura T; Hirai S; Kobayashi M; Horio F; Kawada T
J Agric Food Chem; 2012 Dec; 60(48):11952-8. PubMed ID: 23145898
[TBL] [Abstract][Full Text] [Related]
32. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
[TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory effects of yerba maté extract (Ilex paraguariensis) ameliorate insulin resistance in mice with high fat diet-induced obesity.
Arçari DP; Bartchewsky W; dos Santos TW; Oliveira KA; DeOliveira CC; Gotardo ÉM; Pedrazzoli J; Gambero A; Ferraz LF; Carvalho Pde O; Ribeiro ML
Mol Cell Endocrinol; 2011 Mar; 335(2):110-5. PubMed ID: 21238540
[TBL] [Abstract][Full Text] [Related]
34. Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs.
Serisier S; Leray V; Poudroux W; Magot T; Ouguerram K; Nguyen P
Br J Nutr; 2008 Jun; 99(6):1208-16. PubMed ID: 18053305
[TBL] [Abstract][Full Text] [Related]
35. Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages.
Kang JH; Kim CS; Han IS; Kawada T; Yu R
FEBS Lett; 2007 Sep; 581(23):4389-96. PubMed ID: 17719033
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice.
Furuya DT; Poletto AC; Favaro RR; Martins JO; Zorn TM; Machado UF
Metabolism; 2010 Mar; 59(3):395-9. PubMed ID: 19800637
[TBL] [Abstract][Full Text] [Related]
37. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.
Orellana-Gavaldà JM; Herrero L; Malandrino MI; Pañeda A; Sol Rodríguez-Peña M; Petry H; Asins G; Van Deventer S; Hegardt FG; Serra D
Hepatology; 2011 Mar; 53(3):821-32. PubMed ID: 21319201
[TBL] [Abstract][Full Text] [Related]
38. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice.
Goto T; Teraminami A; Lee JY; Ohyama K; Funakoshi K; Kim YI; Hirai S; Uemura T; Yu R; Takahashi N; Kawada T
J Nutr Biochem; 2012 Jul; 23(7):768-76. PubMed ID: 21889885
[TBL] [Abstract][Full Text] [Related]
39. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet.
Shih CC; Lin CH; Lin WL
Diabetes Res Clin Pract; 2008 Aug; 81(2):134-43. PubMed ID: 18550200
[TBL] [Abstract][Full Text] [Related]
40. Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice.
Hagiwara S; Gohda T; Tanimoto M; Ito T; Murakoshi M; Ohara I; Yamazaki T; Matsumoto M; Horikoshi S; Funabiki K; Tomino Y
Metabolism; 2009 Jul; 58(7):934-45. PubMed ID: 19427656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
